Palbociclib in combination with simvastatin induce severe rhabdomyolysis: a case report

Palbociclib is a selective well-tolerated antineoplastic drug used in the treatment of advanced HER2-negative, estrogen-receptor positive breast cancer that has shown significant improvement in progression-fre...

Source: BMC Neurology - October 22, 2019 Category: Neurology Authors: Vardan Nersesjan, Klaus Hansen, Thomas Krag, Morten Duno and Tina D. Jeppesen Tags: Case report Source Type: research